While its neonatal mortality rate stands at 25.4, the country has managed a 66% reduction in under-five deaths between 1990 to 2015.
The recent Delhi high court trial shows us that the righteous defence of the generic drugmaker in 2013 was nothing more than an attempt at whitewashing the whole sordid affair.
Chronically low investments have made our public health systems fragile and overburdened, such that they have become incapable of reversing India’s TB crisis by themselves.
PM Modi announced the launch of the Pradhan Mantri Matru Vandana Yojana in December 2016, narrowing down the financial assistance of Rs 5,000 to the first birth only.
Under the UK’s National Health Service, healthcare is provided by a single payer – the British government – and is funded by the taxpayer.
“The Centre has drawn up a health plan in which 40% of the fund has to come from states. But why should the state spend on another programme when it already has its own?”
The combined market capitalisation of the companies promoted by the Singh brothers, Malvinder and Shivinder, is now down to Rs 83 billion from nearly Rs 206 billion on the eve of the Ranbaxy sale.
The groups who received the donations aligned themselves with industry goals and may have played a role in an epidemic that led to 42,000 opioid overdose deaths in 2016.
NPPA has increased the price of bare metal stents to Rs7,660 from Rs7,260 and reduced the price of drug-eluting and biodegradable stents to Rs27,890 from Rs29,600.
Absence of treatment is the norm rather than the exception across the continent, but there are several reasons why countries should pay attention.
Each day, thousands of people stream into central Delhi’s LNJP Hospital from across the city and neighbouring states to access healthcare they otherwise wouldn’t be able to afford.
An eclectic mix of activists, generic drug makers, doctors and government officials worked to make Hepatitis C medicine affordable. What next?
Ramdev was scheduled to speak on ‘Cancer Prevention and Treatment: From Ancient Medicine to Modern Medicine’ to an audience of cancer specialists.
The new health insurance proposal opens the government’s purse strings to private interests.
As India’s mental health continues on a downward slope, small initiatives like teaching happiness could go a long way.
Officials say the large migratory population in Unnao and their high-risk behaviour may also be a reason.
Several states have wider and more inclusive insurance schemes, and the government’s ‘world’s largest healthcare programme’ will likely cause unnecessary disruptions.
A new study has shed light on the prevalence of female genital mutilation in India, and the negative physical, psychological and sexual trauma caused by it.
While the Centre has sent a fact finding team to Unnao, the medical fraternity has termed using of the same syringe as a ‘criminal’ act.
It may not really benefit everyone that the insurance takeover of healthcare financing is gripping India.
The Budget speech pitch of ‘Swastha Bharat’ as ‘Samridha Bharat’ is deception, because the allocation for realising that is missing.
Urmilesh discusses Arun Jaitley’s announcement on a new health protection scheme with Dipa Sinha, who teaches at Ambedkar University Delhi, and Hridayesh Joshi, a senior journalist at NDTV.
All stakeholders must ensure that the public debate on healthcare, spurred by this year’s Union Budget, stays alive and the government’s feet are continuously held to fire.
While the current health schemes are flailing, the new one doesn’t inspire much confidence either.
India is not a signatory to international refugee conventions, which it is using as a cover to prevent Rohingya from accessing programmes that would help them with food and healthcare.
Delhi’s RCEP Talks on Intellectual Property Shouldn’t Forget India’s Role as ‘Pharmacy of the World’
India must resist pressure and make sure the deal doesn’t limit the production of life-saving generic drugs here or abroad.
Ayushman Bharat Health Insurance is old wine in a new bottle as over half the target beneficiaries proposed to be covered already stand covered under existing schemes.
The Centre’s special skill in repackaging and re-advertising proposals is now quite apparent.
Why has India chosen the path of expanding medical insurance instead of a more comprehensive approach to health?
Dr Brenda Fitzgerald, director of the US Centers for Disease Control and Prevention, held “certain complex financial interests” that she could not sell in time.
As one country responds with a ban on commercial surrogacy, the market just shifts to the next unregulated destination. An international declaration will thus send the right message against exploitation of women.
NITI Aayog Comes to the Rescue As Health Ministry Clueless on ‘World’s Largest Healthcare Programme’
How much will this scheme cost? What is the timeline for its roll out? Will private sector influence cause exploitation? Only NITI Aayog has the answers.
The southern states of Kerala and Tamil Nadu had very high rates of diabetes in both urban and rural populations.
While the finance minister’s announcement sounds good in theory, the mathematics involved in the realisation of the National Health Protection Scheme makes it look surreal.
Water from ponds and tube wells has been made safe for consumption, reducing water-borne diseases in coastal Odisha.
From prohibitive cancer drugs to making resources available to fight microbial drug resistance, or getting access to timely diagnostics – access issues are the cornerstone for equitable health systems worldwide.
The manner in which two medical colleges with similar case trajectories were dealt with raises serious questions about the propriety of the judicial and administrative orders in both these instances.
The government’s announcement of the National Health Protection Scheme for 10 crore families is, in fact, a massive insurance scheme for 50 crore of India’s poorest.
While the government claims it “will bring healthcare system closer to the homes of people,” it hopes to do this through the private sector, not by strengthening the public health system.
The government announced a new health protection scheme to give Rs 5 lakh to 50 crore poor and vulnerable individuals, despite existing schemes on this hitting roadblocks.